WHO Global Strategy in Eradication of Cervical Cancer
DOI:
https://doi.org/10.32539/bsm.v5i9.328Keywords:
Cervical Cancer, Eradicated, StrategyAbstract
WHO has created a global strategy to accelerate the elimination of cervical cancer
as a public health problem and a world burden. Cervical cancer is a disease that
can be prevented and cured, as long as it is detected early and treated effectively.
Cervical cancer is also a disease that reflects global injustice. The burden is
greatest in low- and middle-income countries, where access to public health
services is limited and screening and treatment for the disease has not been widely
applied. In 2018, nearly 90% of all deaths worldwide occurred in low and middle
income countries. Furthermore, the proportion of women with cervical cancer who
die from the disease is more than 60% in these countries, more than double the
number in many high-income countries, which is only 30%.
Authors
- Patiyus Agustiansyah1*
- Rizal Sanif1
- Siti Nurmaini2
- Irfannuddin3
- Legiran4
- 1Department of Obstetric and Gynecology, Division Oncology of Gynecology, Faculty of Medicine, Universitas Sriwijaya / General Hospital Dr Moh. Hoesin, Palembang, Indonesia
- 2Intelligent System Research Group, Universitas Sriwijaya, Palembang, Indonesia
- 3Department of Physiology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
- 4Department of Anatomy, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Corresponding author Patiyus Agustiansyah — fatiyusagustiansyah@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
